Related Experiment Video
Updated: Aug 25, 2026
Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma
Published on: April 3, 2026
Organ preservation in patients with squamous cancers of the head and neck
James K Schwarz1, William Giese
1Department of Medicine, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA. james.schwarz@roswellpark.org
Abstract:
Treatment strategies that have the potential to improve functional organ preservation in patients who have head and neck cancer are emerging. Clinical research in this field, however, has been limited by the lack of standardized, objective criteria of organ function post treatment and by lack of prospective assessment of organ function in treatment trials [56]. Advances in surgical techniques, radiation techniques, radiation protectants, and combined-modality therapies are promising, but well-planned and executed clinical trials are necessary to determine how best to apply these techniques to patient care.
Insights
Emerging head and neck cancer treatments aim to improve organ preservation. Further clinical trials are needed to establish objective criteria for assessing organ function post-treatment.
Area of Science:
- Oncology
- Surgical Oncology
- Radiation Oncology
Background:
- Head and neck cancer treatment advancements are focusing on functional organ preservation.
- Current clinical research is hindered by a lack of standardized organ function assessment criteria post-treatment.
- Prospective assessment of organ function within treatment trials remains limited.
Purpose of the Study:
- To highlight the need for improved methods to assess organ function after head and neck cancer treatment.
- To emphasize the importance of developing standardized criteria for evaluating treatment efficacy regarding organ preservation.
- To underscore the necessity of well-designed clinical trials for advancing organ-sparing strategies.
Main Methods:
- Review of current and emerging treatment strategies for head and neck cancer.
- Discussion of limitations in clinical research methodology for organ function assessment.
- Identification of key areas for future research and clinical trial design.
Main Results:
- Functional organ preservation is a key goal in evolving head and neck cancer treatment paradigms.
- Significant challenges exist in objectively measuring and prospectively evaluating organ function post-therapy.
- Advances in surgery, radiation, and combined therapies show promise but require rigorous clinical validation.
Conclusions:
- Standardized, objective criteria for organ function assessment are crucial for advancing head and neck cancer treatment.
- Well-designed clinical trials are essential to validate and optimize organ-sparing treatment approaches.
- Future research must prioritize prospective functional outcome assessments to guide clinical decision-making.